These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 877419)

  • 21. Identification and quantification of p-hydroxyethylamphetamine as a novel metabolite of ethylamphetamine in rat by gas chromatography-mass spectrometry.
    Makino Y; Higuchi T; Ohta S; Hirobe M
    Forensic Sci Int; 1989; 41(1-2):83-91. PubMed ID: 2767582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolism of 3-methoxyamphetamine in dog, monkey and man.
    Midha KK; Cooper JK; Bailey K; Hubbard JW
    Xenobiotica; 1981 Feb; 11(2):137-46. PubMed ID: 6894510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of amphetamines by Mycobacterium smegmatis.
    Coutts RT; Foster BC
    Can J Microbiol; 1980 Mar; 26(3):343-9. PubMed ID: 7407711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urine levels of fenethylline and amphetamine after administration of Captagon].
    Iffland R
    Arch Kriminol; 1982; 169(3-4):81-8. PubMed ID: 7082126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An experimental study on bladder carcinogenesis in dogs by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and its urinary metabolites].
    Morishita S; Hamami G; Kamidono S
    Hinyokika Kiyo; 1989 Jan; 35(1):27-38. PubMed ID: 2729018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the metabolism of ditazole in man.
    Maurer H; Kleff I
    Arzneimittelforschung; 1988 Dec; 38(12):1843-5. PubMed ID: 2907728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Isolation of chlorphenoxamine metabolites in human urine and their identification].
    Goenechea S; Rücker G; Brzezinka H; Hoffmann G; Neugebauer M; Pyzik T
    Arzneimittelforschung; 1987 Jul; 37(7):854-9. PubMed ID: 3675683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectra of N-[(S)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetyl] derivatives of chiral amines. Stereochemistry of amphetamine metabolism in the rat.
    Gal J
    Biomed Mass Spectrom; 1978 Jan; 5(1):32-7. PubMed ID: 623891
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary excretion of heroin and its metabolites in man.
    Yeh SY; Gorodetzky CW; McQuinn RL
    J Pharmacol Exp Ther; 1976 Feb; 196(2):249-56. PubMed ID: 1255475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid.
    Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH
    Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative structure-activity relationships in drug metabolism and disposition: pharmacokinetics of N-substituted amphetamines in humans.
    Testa B; Salvesen B
    J Pharm Sci; 1980 May; 69(5):497-501. PubMed ID: 7381729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine excretion studies in man.
    ALLES GA; WISEGARVER BB
    Toxicol Appl Pharmacol; 1961 Nov; 3():678-88. PubMed ID: 13860595
    [No Abstract]   [Full Text] [Related]  

  • 37. Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue.
    Nazarali AJ; Baker GB; Coutts RT; Greenshaw AJ
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):207-14. PubMed ID: 3436344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of (+/-)-N-(n-propyl) amphetamine by Cunninghamella echinulata.
    Coutts RT; Foster BC; Jones GR; Myers GE
    Appl Environ Microbiol; 1979 Mar; 37(3):429-32. PubMed ID: 453824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man.
    Coutts RT; Dawson GW
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):349-52. PubMed ID: 877419
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.